Table 1 Distribution of studied drug indications for discontinued clinical trials in China
Indications of studied drug a | % (n) |
|---|---|
Neoplasms | 24.7 (77) |
Endocrine, nutritional and metabolic diseases | 17.6 (55) |
Circulatory system | 9.0 (28) |
Respiratory system | 7.1 (22) |
Infectious and parasitic diseases | 5.8 (18) |
Digestive system | 5.8 (18) |
Musculoskeletal system and connective tissue | 5.4 (17) |
Mental and behavioural disorders | 5.1 (16) |
Genitourinary system | 4.8 (15) |
Nervous system | 4.5 (14) |
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified | 3.2 (10) |
Blood, blood -forming organs,immune mechanism | 2.2 (7) |
External causes of morbidity and mortality | 1.6 (5) |
Skin and subcutaneous tissue diseases | 1.3 (4) |
Eye and adnexa diseases | 1.3 (4) |
Injury, poisoning and certain other consequences of external causes | 0.6 (2) |